Limited Commercial Adoption and Revenue Generation Strategy: Tenon Medical is an early-stage commercial company with a limited operating history. There is no guarantee that its flagship product, The CATAMARAN SI-Joint Fusion System, will achieve significant market acceptance among healthcare providers or generate sufficient revenue to achieve profitability.

Dependence on Regulatory Approvals and Clearances: The company's ability to market and sell its medical devices is highly contingent upon obtaining and maintaining necessary regulatory clearances and approvals from bodies like the FDA. Any delays, denials, or new post-market requirements could significantly impede its ability to commercialize products.

Significant Competition in SI-Joint Fusion Market: Tenon operates in a highly competitive market, facing well-established companies with greater financial resources, brand recognition, and existing sales channels, such as SI-BONE. This intense competition makes gaining market share and achieving widespread adoption challenging.